Latest Options News

Magnum Mining & Exploration has raised $7 million through an oversubscribed placement to accelerate its critical minerals processing hub in Nevada and expand rare earth exploration in Brazil, aligning with US strategic priorities.

Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.

Cedar Woods Properties has updated its dividend announcement for the six months ending June 2025, confirming a fully franked 19 cents per share payout and revealing key details on its Dividend Reinvestment and Bonus Security Plans.

Cedar Woods Properties has activated its Dividend Reinvestment and Bonus Share Plans for the final 2025 dividend, offering shares at a 2.5% discount and backed by full underwriting from major brokers.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Eclipse Metals has raised $4 million to accelerate drilling and resource upgrades at its Greenland rare earths project, while preparing for a potential NASDAQ dual listing.

Green Technology Metals has successfully raised A$4.5 million through a two-tranche placement to accelerate development of its Seymour Lithium Project in Ontario, reinforcing its position in the North American lithium sector.

ClearVue Technologies has raised A$4.6 million in a strongly supported placement to accelerate international certification and ongoing innovation of its solar façade products.

Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.

Asian Battery Metals PLC’s due diligence drilling at the Maikhan Uul copper-gold project confirms more than 20 metres of massive sulphide mineralisation, validating historic data and advancing its acquisition option.

Sultan Resources has completed a $1 million strategic placement at a premium, positioning itself for key acquisitions and exploration in Namibia and Western Australia.

PYC Therapeutics has reported encouraging pre-clinical results for its RNA therapy candidate PYC-002 targeting Phelan-McDermid Syndrome, supporting plans to enter human trials in 2026. The data demonstrate safety, brain distribution, and gene expression restoration in key disease regions.